VanEck Pharmaceutical ETF (NASDAQ:PPH) Sees Unusually-High Trading Volume – What’s Next?

VanEck Pharmaceutical ETF (NASDAQ:PPH) saw an uptick in trading volume on Tuesday . 110,990 shares changed hands during mid-day trading, a decline of 53% from the previous session’s volume of 233,820 shares.The stock last traded at $85.09 and had previously closed at $86.31.

VanEck Pharmaceutical ETF Price Performance

The firm has a market cap of $546.18 million, a PE ratio of 21.04 and a beta of 0.72. The company has a 50 day simple moving average of $88.27 and a 200-day simple moving average of $92.29.

VanEck Pharmaceutical ETF Increases Dividend

The business also recently disclosed a dividend, which was paid on Monday, December 30th. Stockholders of record on Friday, December 27th were paid a dividend of $0.411 per share. The ex-dividend date of this dividend was Friday, December 27th. This is a positive change from VanEck Pharmaceutical ETF’s previous dividend of $0.36.

Institutional Trading of VanEck Pharmaceutical ETF

A number of institutional investors have recently made changes to their positions in PPH. Stifel Financial Corp raised its holdings in shares of VanEck Pharmaceutical ETF by 13.4% during the third quarter. Stifel Financial Corp now owns 7,810 shares of the company’s stock valued at $742,000 after acquiring an additional 924 shares in the last quarter. Jane Street Group LLC raised its holdings in shares of VanEck Pharmaceutical ETF by 124.0% during the third quarter. Jane Street Group LLC now owns 19,436 shares of the company’s stock valued at $1,847,000 after acquiring an additional 10,759 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of VanEck Pharmaceutical ETF by 1.7% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 160,039 shares of the company’s stock valued at $14,641,000 after acquiring an additional 2,694 shares in the last quarter. Renaissance Technologies LLC raised its holdings in shares of VanEck Pharmaceutical ETF by 85.0% during the second quarter. Renaissance Technologies LLC now owns 25,900 shares of the company’s stock valued at $2,369,000 after acquiring an additional 11,902 shares in the last quarter. Finally, FMR LLC raised its holdings in shares of VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after acquiring an additional 212 shares in the last quarter.

About VanEck Pharmaceutical ETF

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.